Ogata R, Kishino E, Saitoh W, Koike Y, et al. Resistance to cyclin-dependent kinase (CDK) 4/6 inhibitors confers cross-resistance to other CDK inhibitors but not to chemotherapeutic agents in breast cancer cells. Breast Cancer 2020 Aug 28. pii: 10.1007/s12282-020-01150.
PMID: 32860163